Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Precision Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Applied Sciences
1.2.3 Precision Diagnostics
1.2.4 Digital Health and Information Technology
1.2.5 Precision Therapeutics
1.3 Market by Application
1.3.1 Global Oncology Precision Medicine Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Other Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Precision Medicine Market Perspective (2018-2033)
2.2 Oncology Precision Medicine Growth Trends by Region
2.2.1 Global Oncology Precision Medicine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oncology Precision Medicine Historic Market Size by Region (2018-2023)
2.2.3 Oncology Precision Medicine Forecasted Market Size by Region (2024-2033)
2.3 Oncology Precision Medicine Market Dynamics
2.3.1 Oncology Precision Medicine Industry Trends
2.3.2 Oncology Precision Medicine Market Drivers
2.3.3 Oncology Precision Medicine Market Challenges
2.3.4 Oncology Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Precision Medicine Players by Revenue
3.1.1 Global Top Oncology Precision Medicine Players by Revenue (2018-2023)
3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Precision Medicine Revenue
3.4 Global Oncology Precision Medicine Market Concentration Ratio
3.4.1 Global Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Precision Medicine Revenue in 2022
3.5 Oncology Precision Medicine Key Players Head office and Area Served
3.6 Key Players Oncology Precision Medicine Product Solution and Service
3.7 Date of Enter into Oncology Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Precision Medicine Breakdown Data by Type
4.1 Global Oncology Precision Medicine Historic Market Size by Type (2018-2023)
4.2 Global Oncology Precision Medicine Forecasted Market Size by Type (2024-2033)
5 Oncology Precision Medicine Breakdown Data by Application
5.1 Global Oncology Precision Medicine Historic Market Size by Application (2018-2023)
5.2 Global Oncology Precision Medicine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oncology Precision Medicine Market Size (2018-2033)
6.2 North America Oncology Precision Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Oncology Precision Medicine Market Size by Country (2018-2023)
6.4 North America Oncology Precision Medicine Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Precision Medicine Market Size (2018-2033)
7.2 Europe Oncology Precision Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Oncology Precision Medicine Market Size by Country (2018-2023)
7.4 Europe Oncology Precision Medicine Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Precision Medicine Market Size (2018-2033)
8.2 Asia-Pacific Oncology Precision Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncology Precision Medicine Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Precision Medicine Market Size (2018-2033)
9.2 Latin America Oncology Precision Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Oncology Precision Medicine Market Size by Country (2018-2023)
9.4 Latin America Oncology Precision Medicine Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Precision Medicine Market Size (2018-2033)
10.2 Middle East & Africa Oncology Precision Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncology Precision Medicine Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Oncology Precision Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Oncology Precision Medicine Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Oncology Precision Medicine Introduction
11.2.4 Agilent Technologies Revenue in Oncology Precision Medicine Business (2018-2023)
11.2.5 Agilent Technologies Recent Development
11.3 Almac
11.3.1 Almac Company Detail
11.3.2 Almac Business Overview
11.3.3 Almac Oncology Precision Medicine Introduction
11.3.4 Almac Revenue in Oncology Precision Medicine Business (2018-2023)
11.3.5 Almac Recent Development
11.4 ANGLE plc
11.4.1 ANGLE plc Company Detail
11.4.2 ANGLE plc Business Overview
11.4.3 ANGLE plc Oncology Precision Medicine Introduction
11.4.4 ANGLE plc Revenue in Oncology Precision Medicine Business (2018-2023)
11.4.5 ANGLE plc Recent Development
11.5 Asuragen
11.5.1 Asuragen Company Detail
11.5.2 Asuragen Business Overview
11.5.3 Asuragen Oncology Precision Medicine Introduction
11.5.4 Asuragen Revenue in Oncology Precision Medicine Business (2018-2023)
11.5.5 Asuragen Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Detail
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Oncology Precision Medicine Introduction
11.6.4 BGI Group Revenue in Oncology Precision Medicine Business (2018-2023)
11.6.5 BGI Group Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Introduction
11.7.4 Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 BioMérieux
11.8.1 BioMérieux Company Detail
11.8.2 BioMérieux Business Overview
11.8.3 BioMérieux Oncology Precision Medicine Introduction
11.8.4 BioMérieux Revenue in Oncology Precision Medicine Business (2018-2023)
11.8.5 BioMérieux Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Detail
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Oncology Precision Medicine Introduction
11.9.4 Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2018-2023)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Detail
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Oncology Precision Medicine Introduction
11.10.4 Roche Holding AG Revenue in Oncology Precision Medicine Business (2018-2023)
11.10.5 Roche Holding AG Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Detail
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Oncology Precision Medicine Introduction
11.11.4 Gilead Sciences Revenue in Oncology Precision Medicine Business (2018-2023)
11.11.5 Gilead Sciences Recent Development
11.12 Illumina
11.12.1 Illumina Company Detail
11.12.2 Illumina Business Overview
11.12.3 Illumina Oncology Precision Medicine Introduction
11.12.4 Illumina Revenue in Oncology Precision Medicine Business (2018-2023)
11.12.5 Illumina Recent Development
11.13 Konica Minolta
11.13.1 Konica Minolta Company Detail
11.13.2 Konica Minolta Business Overview
11.13.3 Konica Minolta Oncology Precision Medicine Introduction
11.13.4 Konica Minolta Revenue in Oncology Precision Medicine Business (2018-2023)
11.13.5 Konica Minolta Recent Development
11.14 LabCorp
11.14.1 LabCorp Company Detail
11.14.2 LabCorp Business Overview
11.14.3 LabCorp Oncology Precision Medicine Introduction
11.14.4 LabCorp Revenue in Oncology Precision Medicine Business (2018-2023)
11.14.5 LabCorp Recent Development
11.15 MDxHealth
11.15.1 MDxHealth Company Detail
11.15.2 MDxHealth Business Overview
11.15.3 MDxHealth Oncology Precision Medicine Introduction
11.15.4 MDxHealth Revenue in Oncology Precision Medicine Business (2018-2023)
11.15.5 MDxHealth Recent Development
11.16 Myriad Genetics
11.16.1 Myriad Genetics Company Detail
11.16.2 Myriad Genetics Business Overview
11.16.3 Myriad Genetics Oncology Precision Medicine Introduction
11.16.4 Myriad Genetics Revenue in Oncology Precision Medicine Business (2018-2023)
11.16.5 Myriad Genetics Recent Development
11.17 Novartis
11.17.1 Novartis Company Detail
11.17.2 Novartis Business Overview
11.17.3 Novartis Oncology Precision Medicine Introduction
11.17.4 Novartis Revenue in Oncology Precision Medicine Business (2018-2023)
11.17.5 Novartis Recent Development
11.18 OPKO Health
11.18.1 OPKO Health Company Detail
11.18.2 OPKO Health Business Overview
11.18.3 OPKO Health Oncology Precision Medicine Introduction
11.18.4 OPKO Health Revenue in Oncology Precision Medicine Business (2018-2023)
11.18.5 OPKO Health Recent Development
11.19 Pacific Biosciences
11.19.1 Pacific Biosciences Company Detail
11.19.2 Pacific Biosciences Business Overview
11.19.3 Pacific Biosciences Oncology Precision Medicine Introduction
11.19.4 Pacific Biosciences Revenue in Oncology Precision Medicine Business (2018-2023)
11.19.5 Pacific Biosciences Recent Development
11.20 Quest Diagnostics
11.20.1 Quest Diagnostics Company Detail
11.20.2 Quest Diagnostics Business Overview
11.20.3 Quest Diagnostics Oncology Precision Medicine Introduction
11.20.4 Quest Diagnostics Revenue in Oncology Precision Medicine Business (2018-2023)
11.20.5 Quest Diagnostics Recent Development
11.21 Qiagen
11.21.1 Qiagen Company Detail
11.21.2 Qiagen Business Overview
11.21.3 Qiagen Oncology Precision Medicine Introduction
11.21.4 Qiagen Revenue in Oncology Precision Medicine Business (2018-2023)
11.21.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Applied Sciences
Table 3. Key Players of Precision Diagnostics
Table 4. Key Players of Digital Health and Information Technology
Table 5. Key Players of Precision Therapeutics
Table 6. Global Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Oncology Precision Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Oncology Precision Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Oncology Precision Medicine Market Share by Region (2018-2023)
Table 10. Global Oncology Precision Medicine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Oncology Precision Medicine Market Share by Region (2024-2033)
Table 12. Oncology Precision Medicine Market Trends
Table 13. Oncology Precision Medicine Market Drivers
Table 14. Oncology Precision Medicine Market Challenges
Table 15. Oncology Precision Medicine Market Restraints
Table 16. Global Oncology Precision Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Oncology Precision Medicine Market Share by Players (2018-2023)
Table 18. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2022)
Table 19. Ranking of Global Top Oncology Precision Medicine Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Oncology Precision Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oncology Precision Medicine Product Solution and Service
Table 23. Date of Enter into Oncology Precision Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oncology Precision Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Oncology Precision Medicine Revenue Market Share by Type (2018-2023)
Table 27. Global Oncology Precision Medicine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Oncology Precision Medicine Revenue Market Share by Type (2024-2033)
Table 29. Global Oncology Precision Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Oncology Precision Medicine Revenue Market Share by Application (2018-2023)
Table 31. Global Oncology Precision Medicine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Oncology Precision Medicine Revenue Market Share by Application (2024-2033)
Table 33. North America Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Oncology Precision Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Oncology Precision Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Oncology Precision Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Oncology Precision Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Oncology Precision Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Oncology Precision Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Oncology Precision Medicine Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Oncology Precision Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oncology Precision Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Oncology Precision Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Oncology Precision Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Oncology Precision Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Oncology Precision Medicine Product
Table 51. Abbott Laboratories Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Agilent Technologies Company Detail
Table 54. Agilent Technologies Business Overview
Table 55. Agilent Technologies Oncology Precision Medicine Product
Table 56. Agilent Technologies Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 57. Agilent Technologies Recent Development
Table 58. Almac Company Detail
Table 59. Almac Business Overview
Table 60. Almac Oncology Precision Medicine Product
Table 61. Almac Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 62. Almac Recent Development
Table 63. ANGLE plc Company Detail
Table 64. ANGLE plc Business Overview
Table 65. ANGLE plc Oncology Precision Medicine Product
Table 66. ANGLE plc Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 67. ANGLE plc Recent Development
Table 68. Asuragen Company Detail
Table 69. Asuragen Business Overview
Table 70. Asuragen Oncology Precision Medicine Product
Table 71. Asuragen Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 72. Asuragen Recent Development
Table 73. BGI Group Company Detail
Table 74. BGI Group Business Overview
Table 75. BGI Group Oncology Precision Medicine Product
Table 76. BGI Group Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 77. BGI Group Recent Development
Table 78. Bio-Rad Laboratories Company Detail
Table 79. Bio-Rad Laboratories Business Overview
Table 80. Bio-Rad Laboratories Oncology Precision Medicine Product
Table 81. Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 82. Bio-Rad Laboratories Recent Development
Table 83. BioMérieux Company Detail
Table 84. BioMérieux Business Overview
Table 85. BioMérieux Oncology Precision Medicine Product
Table 86. BioMérieux Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 87. BioMérieux Recent Development
Table 88. Bristol Myers Squibb Company Detail
Table 89. Bristol Myers Squibb Business Overview
Table 90. Bristol Myers Squibb Oncology Precision Medicine Product
Table 91. Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 92. Bristol Myers Squibb Recent Development
Table 93. Roche Holding AG Company Detail
Table 94. Roche Holding AG Business Overview
Table 95. Roche Holding AG Oncology Precision Medicine Product
Table 96. Roche Holding AG Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 97. Roche Holding AG Recent Development
Table 98. Gilead Sciences Company Detail
Table 99. Gilead Sciences Business Overview
Table 100. Gilead Sciences Oncology Precision Medicine Product
Table 101. Gilead Sciences Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 102. Gilead Sciences Recent Development
Table 103. Illumina Company Detail
Table 104. Illumina Business Overview
Table 105. Illumina Oncology Precision Medicine Product
Table 106. Illumina Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 107. Illumina Recent Development
Table 108. Konica Minolta Company Detail
Table 109. Konica Minolta Business Overview
Table 110. Konica Minolta Oncology Precision Medicine Product
Table 111. Konica Minolta Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 112. Konica Minolta Recent Development
Table 113. LabCorp Company Detail
Table 114. LabCorp Business Overview
Table 115. LabCorp Oncology Precision Medicine Product
Table 116. LabCorp Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 117. LabCorp Recent Development
Table 118. MDxHealth Company Detail
Table 119. MDxHealth Business Overview
Table 120. MDxHealth Oncology Precision Medicine Product
Table 121. MDxHealth Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 122. MDxHealth Recent Development
Table 123. Myriad Genetics Company Detail
Table 124. Myriad Genetics Business Overview
Table 125. Myriad Genetics Oncology Precision Medicine Product
Table 126. Myriad Genetics Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 127. Myriad Genetics Recent Development
Table 128. Novartis Company Detail
Table 129. Novartis Business Overview
Table 130. Novartis Oncology Precision Medicine Product
Table 131. Novartis Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 132. Novartis Recent Development
Table 133. OPKO Health Company Detail
Table 134. OPKO Health Business Overview
Table 135. OPKO Health Oncology Precision Medicine Product
Table 136. OPKO Health Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 137. OPKO Health Recent Development
Table 138. Pacific Biosciences Company Detail
Table 139. Pacific Biosciences Business Overview
Table 140. Pacific Biosciences Oncology Precision Medicine Product
Table 141. Pacific Biosciences Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 142. Pacific Biosciences Recent Development
Table 143. Quest Diagnostics Company Detail
Table 144. Quest Diagnostics Business Overview
Table 145. Quest Diagnostics Oncology Precision Medicine Product
Table 146. Quest Diagnostics Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 147. Quest Diagnostics Recent Development
Table 148. Qiagen Company Detail
Table 149. Qiagen Business Overview
Table 150. Qiagen Oncology Precision Medicine Product
Table 151. Qiagen Revenue in Oncology Precision Medicine Business (2018-2023) & (US$ Million)
Table 152. Qiagen Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Precision Medicine Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Oncology Precision Medicine Market Share by Type: 2022 VS 2033
Figure 3. Applied Sciences Features
Figure 4. Precision Diagnostics Features
Figure 5. Digital Health and Information Technology Features
Figure 6. Precision Therapeutics Features
Figure 7. Global Oncology Precision Medicine Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Oncology Precision Medicine Market Share by Application: 2022 VS 2033
Figure 9. Breast Cancer Case Studies
Figure 10. Lung Cancer Case Studies
Figure 11. Colorectal Cancer Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Cervical Cancer Case Studies
Figure 14. Other Cancer Case Studies
Figure 15. Oncology Precision Medicine Report Years Considered
Figure 16. Global Oncology Precision Medicine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Oncology Precision Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Oncology Precision Medicine Market Share by Region: 2022 VS 2033
Figure 19. Global Oncology Precision Medicine Market Share by Players in 2022
Figure 20. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Oncology Precision Medicine Revenue in 2022
Figure 22. North America Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Oncology Precision Medicine Market Share by Country (2018-2033)
Figure 24. United States Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Oncology Precision Medicine Market Share by Country (2018-2033)
Figure 28. Germany Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Oncology Precision Medicine Market Share by Region (2018-2033)
Figure 36. China Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Oncology Precision Medicine Market Share by Country (2018-2033)
Figure 44. Mexico Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Oncology Precision Medicine Market Share by Country (2018-2033)
Figure 48. Turkey Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Oncology Precision Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Abbott Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 51. Agilent Technologies Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 52. Almac Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 53. ANGLE plc Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 54. Asuragen Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 55. BGI Group Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 57. BioMérieux Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 58. Bristol Myers Squibb Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 59. Roche Holding AG Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 60. Gilead Sciences Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 61. Illumina Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 62. Konica Minolta Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 63. LabCorp Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 64. MDxHealth Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 65. Myriad Genetics Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 66. Novartis Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 67. OPKO Health Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 68. Pacific Biosciences Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 69. Quest Diagnostics Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 70. Qiagen Revenue Growth Rate in Oncology Precision Medicine Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed